Dr Kim on the Background of a Real-World Study of the Use of Regorafenib in mCRC

Richard Kim, MD, discusses a real-world investigation of long-term responses with regorafenib in metastatic colorectal cancer.

Related Keywords

Richard Kim ,University Of South Florida College Medicine ,Department Of Gastrointestinal Oncology ,Moffitt Cancer Center ,Medical Gastrointestinal Oncology ,Gastrointestinal Oncology ,South Florida College ,Onclive Tv ,Colorectal Cancer ,